Despite Journey Medical's Pullback, Insiders Still Gained US$118k [Yahoo! Finance]
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea